Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa Wilson, Soumen Chakraborty, Shainnel O. Eans, et al.
Cellular and Molecular Neurobiology (2021) Vol. 41, Iss. 5, pp. 1131-1143
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Structure-based discovery of conformationally selective inhibitors of the serotonin transporter
Isha Singh, Anubha Seth, Christian B. Billesbølle, et al.
Cell (2023) Vol. 186, Iss. 10, pp. 2160-2175.e17
Open Access | Times Cited: 45
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
A µ-opioid receptor modulator that works cooperatively with naloxone
Evan S. O’Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Nature (2024) Vol. 631, Iss. 8021, pp. 686-693
Closed Access | Times Cited: 14
An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine
Nur Aisyah Khairul Annuar, Ummi Kalthum Azlan, Ahmed Mediani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116134-116134
Open Access | Times Cited: 9
An In Vitro Examination of Whether Kratom Extracts Enhance the Cytotoxicity of Low-Dose Doxorubicin against A549 Human Lung Cancer Cells
Asep Bayu, Siti Irma Rahmawati, Firmansyah Karim, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1404-1404
Open Access | Times Cited: 8
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F. DiBerto, Abdelfattah Faouzi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13873-13892
Open Access | Times Cited: 50
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Exploring the self-reported motivations of kratom (Mitragyna speciosa Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A. Veltri, Diana Morcos, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 4, pp. 433-444
Closed Access | Times Cited: 31
Clinical Pharmacology, Toxicity, and Abuse Potential of Opioids
David Vearrier, Oliver Grundmann
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 39
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
Docking 14 million virtual isoquinuclidines against the mu and kappa opioid receptors reveals dual antagonists-inverse agonists with reduced withdrawal effects
Seth F. Vigneron, Shohei Ohno, João Braz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Site selective C–H functionalization of Mitragyna alkaloids reveals a molecular switch for tuning opioid receptor signaling efficacy
Srijita Bhowmik, Juraj Galeta, Václav Havel, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom
Soumen Chakraborty, Rajendra Uprety, Amal EI Daibani, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 14, pp. 2661-2678
Open Access | Times Cited: 28
Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
Anna M. Gutridge, Soumen Chakraborty, Balázs R. Varga, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
The Use of Kratom (Mitragyna speciosa Korth.) Among People Who Co-use Heroin and Methamphetamine in Malaysia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Journal of Addiction Medicine (2021) Vol. 16, Iss. 2, pp. 223-228
Closed Access | Times Cited: 27
Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products
Islamudin Ahmad, Wisnu Cahyo Prabowo, Muhammad Arifuddin, et al.
Life (2022) Vol. 12, Iss. 2, pp. 193-193
Open Access | Times Cited: 19
Interactive Effects ofµ-Opioid and Adrenergic-α2Receptor Agonists in Rats: Pharmacological Investigation of the Primary Kratom Alkaloid Mitragynine and Its Metabolite 7-Hydroxymitragynine
Samuel Obeng, Francisco León, Avi Patel, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 383, Iss. 3, pp. 182-198
Open Access | Times Cited: 19
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Endogenous opiates and behavior: 2021
Richard J. Bodnar
Peptides (2023) Vol. 164, pp. 171004-171004
Closed Access | Times Cited: 9
Opioid signaling and design of analgesics
Barnali Paul, Sashrik Sribhashyam, Susruta Majumdar
Progress in molecular biology and translational science (2022), pp. 153-176
Open Access | Times Cited: 14
Kratom as an opioid alternative: harm, or harm reduction? A systematic review of literature
Cornel N. Stanciu, Saeed Ahmed, Samantha A. Gnanasegaram, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 509-528
Closed Access | Times Cited: 14
Clinical Pharmacology of the Dietary Supplement Kratom (Mitragyna speciosa)
Chad Hartley, Marilyn N. Bulloch, Scott Penzak
The Journal of Clinical Pharmacology (2021) Vol. 62, Iss. 5, pp. 577-593
Closed Access | Times Cited: 19
Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant
Alessandro Vento, Simone De Persis, Sergio De Filippis, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top